Determine the mutual inductance per unit length between two long solenoids, one inside the other, whose radii are r1 and r2 (r2

In a wind tunnel the speed changes as the cross sectional area of the tunnel changes. if the speed in a 6' x 6' square test section is 100 mph, what was the speed upstream of the test section where the tunnel measured 20' x 20'? use conservation of mass and assume incompressible flow. conservation of mass requires that as the flow moves through a path or a duct the product of the density, velocity and cross sectional area must remain constant; i.e., that ova-constant. a model is being tested in a wind tunnel at a speed of 100 mph if the flow in the test section is at sea level standard conditions, what is the pressure at the model's stagnation point? (a) the tunnel speed is being measured by a pitot-static tube connected to a u- tube manometer. what is the reading on that manometer in inches of water? (b) at one point on the model a pressure of 2058 psf is measured. what is the local airspeed at that point?

Sawyer is studying diffraction. he draws a diagram of a plane wave to show how light waves travel. which best describes sawyer’s error? the wave fronts should be perpendicular to the direction in which the waves move. the arrow showing the direction of movement of the waves should be pointing to the left. the arrow showing the direction of movement of the waves should be pointing downward. the wave fronts should be both parallel and perpendicular to the direction in which the waves move.

Asubject in a clinical research trial experiences a serious, unanticipated adverse drug experience. how should the investigator proceed, with respect to the irb, after the discovery of the adverse event occurrence? a. do not report the adverse drug experience to the irb since it is a common adverse experience.b. report the adverse drug experience to the irb only if there are several other occurrences.c. report the adverse drug experience as part of the continuing review report.d. report the adverse drug experience in a timely manner, in keeping with the irb's policies and procedures, using the forms or the mechanism provided by the irb.